Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Inhibition of methotrexate-induced chromosomal damage by folinic acid in V79 cells.

Keshava C, Keshava N, Whong WZ, Nath J, Ong TM.

Mutat Res. 1998 Feb 2;397(2):221-8.

PMID:
9541646
2.

Inhibitory effect of folinic acid on radiation-induced micronuclei and chromosomal aberrations in V79 cells.

Keshava C, Nagalakshmi R, Ong T, Nath J.

Mutat Res. 1996 Jun 10;352(1-2):123-34.

PMID:
8676901
3.

Inhibition of methotrexate-induced chromosomal damage by vanillin and chlorophyllin in V79 cells.

Keshava C, Keshava N, Whong WZ, Nath J, Ong TM.

Teratog Carcinog Mutagen. 1997-1998;17(6):313-26.

PMID:
9485540
4.

Protective effect of vanillin on radiation-induced micronuclei and chromosomal aberrations in V79 cells.

Keshava C, Keshava N, Ong TM, Nath J.

Mutat Res. 1998 Feb 2;397(2):149-59.

PMID:
9541639
5.

Protective effect of folinic acid on low-dose methotrexate genotoxicity.

Shahin AA, Ismail MM, Saleh AM, Moustafa HA, Aboul-Ella AA, Gabr HM.

Z Rheumatol. 2001 Apr;60(2):63-8.

PMID:
11383050
6.

Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.

Padmanabhan S, Tripathi DN, Vikram A, Ramarao P, Jena GB.

Mutat Res. 2009 Feb 19;673(1):43-52. doi: 10.1016/j.mrgentox.2008.11.011. Epub 2008 Dec 6.

PMID:
19110071
7.
8.

Folinic acid protects against suppression of growth by methotrexate in mice.

Iqbal MP, Sultana F, Mehboobali N, Pervez S.

Biopharm Drug Dispos. 2001 May;22(4):169-78.

PMID:
11745919
9.
10.

Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.

Fan C, Cool JC, Scherer MA, Foster BK, Shandala T, Tapp H, Xian CJ.

Bone. 2009 Jan;44(1):61-70. doi: 10.1016/j.bone.2008.09.014. Epub 2008 Oct 11.

PMID:
18976724
11.

Effect of methotrexate and folinic acid on skeletal growth in mice.

Iqbal MP, Ahmed M, Umer M, Mehboobali N, Qureshi AA.

Acta Paediatr. 2003 Dec;92(12):1438-44.

PMID:
14971796
12.

Reduction of genotoxic effects of N-nitrosomorpholine in human hepatoma cells and hamster lung cells by carboxymethyl chitin-glucan.

Slamenova D, Sramkova M, Chalupa I, Smigova J, Kogan G.

Neoplasma. 2008;55(4):280-5.

PMID:
18505337
13.

Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells.

Xian CJ, Cool JC, Scherer MA, Fan C, Foster BK.

J Cell Physiol. 2008 Mar;214(3):777-85.

PMID:
17786974
14.

Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.

Bernard S, Etienne MC, Fischel JL, Formento P, Milano G.

Br J Cancer. 1991 Feb;63(2):303-7.

15.
16.

Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.

van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB.

Rheumatology (Oxford). 2002 Jun;41(6):658-65.

PMID:
12048292
17.

Effect of methotrexate and folinic acid on accumulation of iron in mice.

Iqbal MP, Mehboobali N, Sultana F, Khan FB, Burney IA, Kakepoto GN.

Med Hypotheses. 2003 Oct;61(4):444-5.

PMID:
13679009
18.

Amelioration by leucovorin of methotrexate developmental toxicity in rabbits.

DeSesso JM, Goeringer GC.

Teratology. 1991 Mar;43(3):201-15.

PMID:
2014483
19.

[Effect of folinic acid (leucovorin) on cytotoxic and cytogenetic effects of methotrexate].

Pieńkowska K, Koziorowska J.

Folia Med Cracov. 1986;27(3-4):239-44. Polish. No abstract available.

PMID:
3494651
20.

Supplemental Content

Support Center